arrow
BackJournal Details
European Journal of Heart Failure cover

European Journal of Heart Failure

IF10.8
Papers23242
Citations25567
Journal Papers 23242
Publication Date
Management of Heart transplant recipients for the non Heart Transplant health care provider. A Clinical Consensus Statement of the Heart Failure Association (HFA) and the Association of Cardiovascular Nursing & Allied Professions (ACNAP) of the ESC
delete2026-10-19
delete0
deleteOAAI
deleteGuillaume Baudry; Emer Joyce; Marianna Adamo; Rafaela Batista dos Santos Pedrosa; Tuvia Ben Gal; Michael Bonios; Maria Generosa Crespo-Leiro; Ida E Hoejskov; Attilio Iacovoni; Chris Kapelios; Hoong Sern Lim; Marco Metra; Felix Schoenrath; Hadi Skouri; Linda W Van Laake; Kevin Damman; null
deleteShare
deleteSave
GLP-1 receptor agonist treatment and cardiovascular outcomes following aortic valve replacement: a nationwide observational study
delete2026-10-16
delete0
PREAI
deleteLytfi Krasniqi, MD PhD; Mohanad Hamandi, MD; Poul Erik Mortensen, MD; Henrik Nissen, MD, PhD; Patricia A Pellikka, MD; Barry A Borlaug, MD; Oke Gerke, MSc, PhD, DMSc; Amal Haujir, MD; Louise Oeksnebjerg Krasniqi, MSc; Christian Juhl Terkelsen, MD, PhD, DMSci; Lars Peter Riber, MD, PhD, DMSc; Jordi Sanchez Dahl, MD, PhD, DMSc
deleteShare
deleteSave
Guideline directed medical therapy and decongestion in patients with acute heart failure
delete2026-10-13
delete0
PREAI
deleteJuan B Ivey-Miranda, MD; Zachary L Cox, PharmD; Veena S Rao, PhD; Julieta Moreno-Villagomez, PhD; Daniela Ramos-Mastache, PhD; Christopher Maulion, MD; Lavanya Bellumkonda, MD; Jeffrey M Turner, MD; Yu Yamamoto, MS; Javed Butler, MD; Jan Biegus, MD, PhD; Piotr Ponikowski, MD, PhD; Jozine ter Maaten, MD, PhD; Kevin Damman, MD, PhD; Julio Nunez, MD; Mark C Petrie, MD; F Perry Wilson, MD, MSCE; Jeffrey M Testani, MD, MTR
deleteShare
deleteSave
“Baseline Characteristics and Utilization of Medical Therapies in Acute Hospitalized and Chronic Heart Failure Patients Enrolled in GRASP-HF: Differences Between ICARe-HF and Non-ICARe-HF Centres”
delete2026-10-13
delete0
PREAI
deleteOvidiu Chioncel; Gianluigi Savarese; Cecile Laroche; Offer Amir; Mariya Tokmakova; Mathilde Boutard; Antonio Cannata; Hamlet Hayrapetyan; Hans-Eckart Sarnighausen; Noha El Ouafi; Emilie Soriano; Brenda Moura; Lars Lund; Marianna Adamo; Wendy Guillouche; Maurizio Volterani; Bernard Iung; Wilfried Mullens; Marco Metra; GRASP-HF Study National Leaders and Investigators
deleteShare
deleteSave
The Polypill: The Unmet Need and Great Hope for Heart Failure Patients
delete2026-10-13
delete0
PREAI
deleteJan Biegus, MD, PhD; Michael Böhm, MD, PhD; Javed Butler, MD, PhD; Piotr Ponikowski, MD, PhD
deleteShare
deleteSave
Consistency of the effect of digoxin across clinical subgroups in heart failure with reduced ejection fraction: insights from the DIG trial
delete2026-10-13
delete0
PREAI
deleteMisato Chimura, MD, PhD; Kieran F Docherty, MBChB, PhD; Ross T Campbell, MD; Roy S Gardner, MD; Alasdair D Henderson, PhD; Matthew M Y Lee, MBChB, PhD; Mark C Petrie, MBChB; Pardeep S Jhund, MBChB, MSc, PhD; John J V McMurray, MD
deleteShare
deleteSave
Clinical trajectory and disease progression in patients with cardio-renal-metabolic syndrome: the CaReMap observational study
delete2026-10-09
delete0
deleteOAAI
deleteFederico Turoldo; Giulia Barbati; Cinzia Radesich; Vittorio Di Maso; Riccardo Candido; Manuela Bosco; Arjuna Scagnetto; Simona Barzaghi; Serena Falato; Carla Scognamillo; Andrea di Lenarda
deleteShare
deleteSave
GDMT is Associated with Reduced Loop Diuretic Requirements, Whereas Diuretic Dose Does Not Modify GDMT Benefit in Heart Failure: STRONG-HF.
delete2026-10-09
delete0
PREAI
deleteJan Biegus, MD, PhD; Beth Davison, PhD; Gad Cotter, MD; Christopher Edwards, BSc; Jelena Čelutkienė, MD, PhD; Ovidiu Chioncel, MD, PhD; Alain Cohen-Solal, MD, PhD; Gerasimos Filippatos, MD; Maria Novosadova, MD; Karen Sliwa, MD; Marianela Barros, MD; Albertino Damasceno, MD, PhD; Matteo Pagnesi, MD PhD; Hadiza Saidu, MBBS; Koji Takagi, MD; Alexandre Mebazaa, MD, PhD; Adriaan A Voors, MD, PhD; Marco Metra, MD, PhD; Piotr Ponikowski, MD, PhD
deleteShare
deleteSave
Longitudinal proteomic organ-specific aging in heart failure
delete2026-09-25
delete0
PREAI
deleteKaiyong Qu; Ernest Diez Benavente; Ezgi Hatip Ünlü; Anne-Mar L N van Ommen; M Louis Handoko; Arco J Teske; Maarten Jan Cramer; Folkert W Asselbergs; Frans H Rutten; Eric Boersma; Hester M den Ruijter; N Charlotte Onland-Moret; Isabella Kardys; Elisa Dal Canto
deleteShare
deleteSave
MAGGIC and PREDICT-HF Models in the VICTOR Trial: Do Traditional Risk Scores Still Work in Well-Treated Ambulatory Patients with HFrEF?
delete2026-09-21
delete0
PREAI
deleteMichele Senni⁠; Javed Butler; Derek Cyr; Kevin J Anstrom; Irina Barash; Marc P Bonaca; Matthew Budoff; Myeong-Chan Cho; Maria Generosa Crespo-Leiro; Stefano Corda; Justin Ezekowitz; Carolyn S P Lam; Eldrin F Lewis; JoAnn Lindenfeld; Ciaran J McMullan; Robert J Mentz; Christopher M O’Connor; Piotr Ponikowski; Yogesh N V Reddy; Giuseppe Rosano; Clara Saldarriaga; James Udelson; Jose Vazquez-Tanus; Adriaan A Voors; Faiez Zannad
deleteShare
deleteSave
Mortality benefit and lifetime survival gains with vericiguat in HFrEF: Bayesian and actuarial analyses of the VICTOR trial
delete2026-09-16
delete0
deleteOAAI
deleteFrancesco Fioretti; Faiez Zannad; Derek Cyr; Kevin J Anstrom; Irina Barash; Marc P Bonaca; Stefano Corda; Anique Ducharme; Justin Ezekowitz; Anuradha Lala; Carolyn S P Lam; Eldrin F Lewis; JoAnn Lindenfeld; Ciaran J McMullan; Robert J Mentz; Marco Metra; Alanna A Morris; Christopher M O’Connor; Piotr Ponikowski; Yogesh N V Reddy; Giuseppe Rosano; Clara Saldarriaga; Michele Senni; James Udelson; Adriaan A Voors; Javed Butler
deleteShare
deleteSave
Fragility metrics are the wrong tool for finerenone's cardiovascular evidence
delete2026-09-16
delete0
PREAI
deleteShankar Biswas⁠; Yashasvi Srivastava; Susruth Kumar Bandaru
deleteShare
deleteSave
Phenotype-specific prognostic implications of pulse pressure in heart failure
delete2026-09-11
delete0
PREAI
deleteMisato Chimura; Kieran F Docherty; Alasdair D Henderson; Akshay S Desai; Michel Komajda; Milton Packer; Marc A Pfeffer; Bertram Pitt; John R Teerlink; Muthiah Vaduganathan; Faiez Zannad; Michael R Zile; Pardeep S Jhund; Scott D Solomon; John J V McMurray⁠
deleteShare
deleteSave
Target-dose vs below-target-dose lisinopril and fosinopril in HFrEF with advanced CKD
delete2026-09-09
delete0
PREAI
deleteAmiya A Ahmed; Frederick Lu; Hans J Moore; Tariq Ahmad; Wen-Chih Wu; Samir S Patel; Phillip H Lam; Charity J Morgan; Stefan D Anker; Paul A Heidenreich; Gregg C Fonarow; Ali Ahmed
deleteShare
deleteSave
Pharmacological optimisation in the treatment of Heart Failure in Women (PopS-HF): rationale and design of a prospective pragmatic, multicentre, randomised trial
delete2026-09-08
delete0
PREAI
deleteAndrea Attanasio; Giandomenico Disabato; Gianluigi Guida⁠; Federico Ambrogi; Piergiuseppe Agostoni; Giovanna Landi; Carlo Piccinni; Aldo P Maggioni; Massimo Piepoli
deleteShare
deleteSave
Efficacy of vericiguat by background guideline-directed medical therapy in the VICTOR trial
delete2026-09-08
delete0
deleteOAAI
deleteJustin A Ezekowitz; Javed Butler; Derek Cyr; Kevin J Anstrom; Irina Barash; Marc P Bonaca; Stefano Corda; Carolyn S P Lam; Eldrin F Lewis; JoAnn Lindenfeld; Ciaran J McMullan; Robert J Mentz; Christopher M O’Connor; Piotr Ponikowski; Yogesh N V Reddy; Giuseppe Rosano; Clara Saldarriaga; Michele Senni; Stefan Störk; James E Udelson; Adriaan A Voors; Henrik Wiggers; Faiez Zannad
deleteShare
deleteSave
RSV vaccine for preventing respiratory and cardiovascular hospitalizations in heart failure: a prespecified analysis of the extended DAN-RSV trial
delete2026-09-07
delete0
deleteOAAI
deleteKristoffer Grundtvig Skaarup; Mats C H Lassen; Marat Yafasov; Manan Pareek; Sine H Christensen; Niklas Dyrby Johansen; Abby E Rudolph; Carmen Rodriguez-Tenreiro-Sánchez; Daniel Modin; Brian L Claggett; Carsten S Larsen; Lykke Larsen; Lothar Wiese; Michael Dalager-Pedersen; Matias G Lindholm; Anne Marie Reimer Jensen; Maria Dons; Katrine F Bernholm; Filip S Davidovski; Lisa Steen Duus; Camilla I Ottosen; Anne B Nielsen; Julie H Borchsenius; Caroline Espersen; Guldas Köse; Frederik H Fussing; Ingrid T Lenz; Jacob Christensen; Jakob Ø Simonsen; Majid Afzal; Katja V Bartholdy; Adam C F Langhoff; Lars Køber; Scott D Solomon; Jens Ulrik Stæhr Jensen; Cyril Jean-Marie Martel; Iago Giné-Vázquez; Carmen Duran-Parrondo; Marta Piñeiro-Sotelo; Martín Cribeiro-González; Mónica Conde-Pájaro; Susana Mirás-Carballal; Juan-Manuel González-Pérez; Bradford D Gessner; Negar Aliabadi; Claudia Schwarz; Mette Skovdal; Lawrence H Moulton; Pingping Zhang; Vanessa López-Gómez; Sabrina Welsh; Laura Anatale-Tardiff; Alejandro Cane; Kyla Hayford; Federico Martinón-Torres; Elizabeth Begier; Tor Biering-Sørensen⁠
deleteShare
deleteSave
Interpreting potential benefit on secondary outcomes when a trial fails to meet its primary endpoint
delete2026-09-07
delete0
PREAI
deleteYogesh N V Reddy; Javed Butler; Jan G P Tijssen; Faiez Zannad
deleteShare
deleteSave
Hierarchical composite endpoints in heart failure trials: clarity or confusion?
delete2026-09-07
delete0
PREAI
deleteAyobami Omodara; Birgit Aßmus; Klaus K Witte⁠; Sam Straw
deleteShare
deleteSave